Skip to main content
OpenTrials

Clinical trial condition

Vaccinia

Explore clinical trials studying Vaccinia. Study availability and eligibility vary by location and protocol.

48 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Vaccinia trial results

Recruiting

IDOV-Immune for Advanced Solid Tumors

NCT06910657

Conditions
Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +94 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
  • Westmead Hospital Westmead, New South Wales, Australia
View Trial Details
Recruiting

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

NCT05281471

Conditions
Adnexal Diseases, DNA Virus Infections, Endocrine Gland Neoplasms, +26 more
Locations
  • The University of South Alabama, Mitchell Cancer Institute Mobile, Alabama, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • UC San Diego Health - Moores Cancer Center La Jolla, California, United States
View all 32 locations
View Trial Details
Recruiting

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

NCT06463665

Conditions
Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Bronchial Neoplasms, +23 more
Locations
  • Pioneer Research Center, LLC Bullhead City, Arizona, United States
  • Clermont Oncology Center Clermont, Florida, United States
  • Oncology & Hematology Associates of West Broward Coral Springs, Florida, United States
  • Helios Clinical Research Fort Lauderdale, Florida, United States
View all 15 locations
View Trial Details
Completed

A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib

NCT01387555

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
Locations
  • Moores University of California San Diego Cancer Center La Jolla, California, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
View all 38 locations
View Trial Details

Related conditions